VYNT
Vyant Bio, Inc. Common Stock
VYNT
VYNT
Delisted
VYNT was delisted on the 12th of May, 2023.
23 hedge funds and large institutions have $2.54M invested in Vyant Bio, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
23
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$50K | |
| 2 | +$33.9K | |
| 3 | +$9.05K | |
| 4 |
AWM
AE Wealth Management
Topeka,
Kansas
|
+$3.8K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.08K |
Top Sellers
| 1 | -$277K | |
| 2 | -$134K | |
| 3 | -$111K | |
| 4 |
VF
Virtu Financial
New York
|
-$64K |
| 5 |
JPMPWA
J.P. Morgan Private Wealth Advisors
San Francisco,
California
|
-$55K |